Mississauga, Canada
Dalriada Drug Discovery, founded in 2017, is a Canadian pharmaceutical startup that excels in facilitating small molecule drug discovery. The company operates under its proprietary TURN-KEY™ model, designed to streamline research and development efforts in sync with business objectives and intellectual property strategies.
Headquartered in Canada, Dalriada has positioned itself as a key player in the drug discovery ecosystem by building specialized teams skilled in Medicinal Chemistry, Biology, and ADME. This enables them to push forward projects efficiently, fostering innovation for both startups and large corporations.
Despite its strong foothold in the industry, Dalriada has not disclosed any recent investment activities, which presents a unique opportunity for potential investors to engage with an agile and promising company at the forefront of pharmaceutical innovation.
Forensic Fluids Laboratories
